Runben Biotechnology Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Apr '25 Apr 23, 2025	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
Market Capitalization	14,112	7,356	-	-	-	-
Enterprise Value	13,719	6,808	-	-	-	-
Last Close Price	34.88	17.89	-	-	-	-
PE Ratio	45.93	32.54	-	-	-	-
Forward PE	44.97	26.80	-	-	-	-
PS Ratio	11.32	7.12	-	-	-	-
PB Ratio	6.91	3.83	-	-	-	-
P/TBV Ratio	6.98	3.87	-	-	-	-
P/FCF Ratio	72.66	30.79	-	-	-	-
P/OCF Ratio	58.31	29.13	-	-	-	-
EV/Sales Ratio	11.00	6.59	-	-	-	-
EV/EBITDA Ratio	42.38	25.96	-	-	-	-
EV/EBIT Ratio	45.68	28.06	-	-	-	-
EV/FCF Ratio	70.64	28.50	-	-	-	-
Debt / Equity Ratio	0.00	0.00	0.01	0.02	-	-
Debt / EBITDA Ratio	0.01	0.02	0.04	0.07	-	-
Debt / FCF Ratio	0.02	0.02	0.06	-	-	-
Asset Turnover	0.78	0.73	1.16	1.26	2.01	-
Inventory Turnover	4.67	4.64	4.93	5.40	5.64	-
Quick Ratio	2.37	16.93	3.97	3.64	3.72	1.53
Current Ratio	10.60	18.04	5.28	4.56	5.85	2.92
Return on Equity (ROE)	20.79%	17.10%	24.93%	29.72%	48.88%	-
Return on Assets (ROA)	11.71%	10.66%	15.06%	17.69%	30.29%	-
Return on Capital (ROIC)	12.71%	11.42%	17.02%	19.86%	34.46%	-
Return on Capital Employed (ROCE)	14.70%	12.60%	24.30%	22.90%	42.40%	33.60%
Earnings Yield	2.17%	3.07%	-	-	-	-
FCF Yield	1.38%	3.25%	-	-	-	-
Dividend Yield	0.55%	0.95%	-	-	-	-
Payout Ratio	22.46%	-	2.15%	25.65%	-	-
Buyback Yield / Dilution	-19.70%	-3.71%	-1.61%	-9.69%	-499.54%	-
Total Shareholder Return	-19.16%	-2.76%	-1.61%	-9.69%	-499.54%	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.